Skip to main content
. 2017 Feb 9;2017(2):CD003543. doi: 10.1002/14651858.CD003543.pub4

Willemsen 2010.

Methods STUDY DESIGN: ITS
Risk of Bias: LOW
Participants PROVIDERS: all physicians in the hospital
 PARTICIPANTS: all patients receiving therapeutic antibiotics
 CLINICAL PROBLEM: decrease use of ciprofloxacin
 SETTING: 1 hospital in the Netherlands
Interventions FORMAT: Interventions: educational meetings with dissemination of guidelines; educational outreach by review and recommend change; reminders (physical, newsletter and on all microbiology reports saying that ciprofloxacin should be prescribed on strict indications only)
 Intervention Functions: education, enablement, environmental restructuring, persuasion
 DELIVERER: AMT
 COMPARISON: usual care
 DESIRED CHANGE: decrease excessive
Outcomes PRESCRIBING: Choice: prescribed daily doses of ciprofloxacin (IV and oral)
MICROBIAL: % quionolone‐resistant gram‐negative clinical isolates
Notes FINANCIAL SUPPORT: Funding: Amphia Hospital, Breda/Oosterhout, Netherlands. Competing Interests: none declared
ADDITIONAL DATA: no response from authors to request for additional data
Microbial Risk of Bias: LOW Case definition infection with quionolone‐resistant gram‐negative bacteria, Planned intervention Low, Other infection control Low, no changes (information in Discussion)
Risk of bias
Bias Authors' judgement Support for judgement
Intervention independent (ITS) ? Low risk  
Analysed appropriately (ITS) ? Low risk Segmented regression analysis
Shape of effect pre‐specified (ITS) ? Low risk Point of intervention was point of analysis.
Unlikely to affect data collection (ITS) ? Low risk Outcomes from pharmacy and microbiology computers
Knowledge of the allocation adequately prevented(ITS)? Low risk Outcomes from pharmacy and microbiology computers
Incomplete outcome data addressed (ITS) ? Low risk Outcomes from pharmacy and microbiology computers
Free of selected reporting (ITS) ? Low risk Outcomes from pharmacy and microbiology computers
Free of other bias (ITS) ? Low risk 1 year data pre‐ and postintervention